Fate Therapeutics Inc. buy Barclays PLC
Start price
14.05.25
/
50%
€0.86
Target price
14.05.26
€1.79
Performance (%)
12.20%
Price
31.07.25
€0.97
Summary
This prediction is currently active. The prediction currently has a performance of 12.20%. This prediction currently runs until 14.05.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | -8.631% | -8.631% |
| iShares Core DAX® | -1.074% | 0.201% |
| iShares Nasdaq 100 | 3.110% | 5.822% |
| iShares Nikkei 225® | -2.154% | -0.860% |
| iShares S&P 500 | 2.634% | 5.633% |
Comments by Barclays_PLC for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target lowered by analysts at Barclays PLC from $10.00 to $2.00. They now have an "overweight" rating on the stock.
Ratings data for FATE provided by MarketBeat
Stopped prediction by Barclays_PLC for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.42
27.02.24
27.02.24
€9.22
27.02.25
27.02.25
-81.86%
28.02.25
28.02.25
